60 Degrees Pharmaceuticals Warrant
SXTPW
9 hedge funds and large institutions have $36.7K invested in 60 Degrees Pharmaceuticals Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
0.16% more ownership
Funds ownership: 13.34% → 13.5% (+0.16%)
86% less capital invested
Capital invested by funds: $261K → $36.7K (-$224K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$755 |
| 2 |
VF
Virtu Financial
New York
|
-$149 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $12.3K | – | – | – |
|
2
Walleye Capital
New York
| $11.1K | – | – | – |
|
|
CS
3
Clear Street
New York
| $7.63K | – | – | – |
|
|
TC
4
Torno Capital
Cohasset,
Massachusetts
| $2.36K | +$5.97K | +47,169 | New |
|
|
WAM
5
Warberg Asset Management
Winnetka,
Illinois
| $2.07K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $1K | -$149 | -1,180 | -6% |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $200 | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $4 | -$755 | -5,965 | -98% |
|
9
Bank of America
Charlotte,
North Carolina
| $4 | – | – | – |
|
SXTPW Hedge Fund Activity: Q4 2023 in Review
9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q4 2023, worth a combined $36.7K — down 86% from $261K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SXTPW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest seller was UBS Group, cutting an estimated $755.
- 9 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q4 2023, up from 8 in Q3 2023.
- Funds reported $36.7K of 60 Degrees Pharmaceuticals Warrant stock for Q4 2023, down 86% quarter-over-quarter.
- 1 fund opened new 60 Degrees Pharmaceuticals Warrant positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest 60 Degrees Pharmaceuticals Warrant seller in Q4 2023 was UBS Group, an estimated $755 sold.
Based on aggregated 13F filings for Q4 2023.